Products for Research Use Only

CYP3A4 Antibody Blocking peptide

CAT: 0013-GTR18965330Size: 500 µgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR18965330Size:500 µg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CYP3A4 Antibody Blocking peptide
Product Name Alternative
Cytochrome P450 3A4, 11413-,8-cineole 2-exo-monooxygenase, Albendazole monooxygenase, Albendazole sulfoxidase, CYPIIIA3, CYPIIIA4, Cytochrome P450 3A3, Cytochrome P450 HLp, Cytochrome P450 NF-25, Cytochrome P450-PCN1, Nifedipine oxidase, Quinine 3-monooxygenase, Taurochenodeoxycholate 6-alpha-hydroxylase, CYP3A4, CYP3A3
UniProt
P08684
Field of Research
Metabolism Research
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence used to generate the antibody orb1928893 was selected from the Center region of human CYP3A4. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

UniProtKB · P08684

Cytochrome P450 3A4

CP3A4_HUMAN · Homo sapiens

View on UniProt ↗
Primary accession
P08684
Review status
UniProtKB reviewed (Swiss-Prot)
Gene
CYP3A4
Protein existence
1: Evidence at protein level
Organism
Homo sapiens (Human)
Taxonomy ID
9606
Alternative names
—
EC number
1.14.14.1
Processing
—
Secondary accessions
P05184, Q16757, Q9UK50
Protein keywords

Technical term

3D-structureDirect protein sequencingProteomics identificationReference proteome

Disease

Disease variant

Cellular component

Endoplasmic reticulumMembraneMicrosome

Biological process

Fatty acid metabolismLipid biosynthesisLipid metabolismSteroid biosynthesisSteroid metabolismSterol metabolism

Ligand

HemeIronMetal-binding

Molecular function

MonooxygenaseOxidoreductase

Domain

TransmembraneTransmembrane helix

PTM

Ubl conjugation